Semaglutide is a GLP-1 agonist, Tirzepatide is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) agonist, and Retatrutide is a triple GLP-1/GIP/glucagon agonist
Studies suggest that protein intake can help decrease ghrelin levels, thus reducing hunger
Dealing with Precautionary measures: To prevent contamination, thoroughly wash one's hands before handling semaglutide or any associated supplies
Seek urgent medical attention (contact 111 or attend A&E) if you develop: Severe, sudden-onset headache ("thunderclap" pattern) unlike any previous headache Headache with fever, rash, or altered consciousness Persistent vomiting preventing fluid intake or medicine absorption Visual changes including double vision, blind spots, or temporary vision loss Signs of severe dehydration (dark urine, dizziness on standing, reduced urination) Symptoms suggesting pancreatitis (severe upper abdominal pain radiating to the back) Symptoms suggesting gallbladder problems (right upper abdominal pain, fever, yellowing of skin/eyes) Your healthcare provider needs to assess whether headaches represent a straightforward medicine side effect or indicate a more complex issue
If you feel unusually tired after starting a GLP-1 medication, the answer is not always your thyroid is off. It could be the drug itself, reduced calorie intake, dehydration, or a real thyroid dose mismatch
How can I ensure Im receiving authentic Ozempic from my pharmacy
